中药多途径给药联合西医治疗肝衰竭/重型肝炎的Meta分析
作者:
作者单位:

1. 广州中医药大学第一临床医学院,广东 广州 510405;2. 广州中医药大学第一附属医院,广东 广州 510405

作者简介:

通讯作者:

中图分类号:

R259

基金项目:

* 基金项目: 国家科技重大专项(2011ZX09102-009)
收稿日期: 2016 - 04- 07
作者简介: 李燕(1994-),女,广东韶关人,在读硕士研究生,研究方向:中医治疗内科疾病。
△通信作者:朱敏,E-mail:1301864172@qq.com


Meta-Analysis of Multi-Ways of Chinese Medcine Combined with Western Medicine in the Treatment of Liver Failure/Severe Hepatitis
Author:
Affiliation:

Guangzhou University of Chinese Medicine, Guangzhou 510405, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的〓利用Meta分析中药多途径给药联合西医治疗肝衰竭/重型肝炎的临床疗效及安全性。方法〓检索Pubmed、Cochrane Library以及CNKI、CBM、万方数据库、维普数据库中建库至2017年1月的相关文献,收集所有随机对照临床试验,获得相关信息。应用Cochrane风险偏倚评估工具进行文献质量方法学评价,采用revman5.3软件进行资料分析。结果〓共纳入23个研究,Meta分析显示:中药多途径给药联合西医治疗肝衰竭/重型肝炎在提高有效率、降低死亡率、改善肝功能、降低血氨及内毒素优于西医对照组(P<0.05)。结论〓中药多途径给药联合西医治疗肝衰竭/重型肝炎优于纯西医对照组。但所纳入的文献质量低,尚需大量的高质量的随机对照试验去验证其疗效及安全性。

    Abstract:

    Objective To meta-analyze the clinical curative effect and safety of multi-ways of using Chinese medicine combined with western medicine in the treatment of iver failure. Methods Searching related literatures from Pubmed, the Cochrane Library and database of CNKI, CBM, WANFANG, WEIPU from the time its built to January, 2017. Collect all randomized controlled clinical trials. Application of the Cochrane risk of bias assessment tool for literature methodology quality score was used. Using revman 5.3 methods in the system to analyze data. Results 23 researches were included. Meta analysis showed that: when compared with the control group, the multi-ways of using Chinese medicine combined with western medicine treated on liver failure was superior in the total effective rates and liver function, lower in the mortality, blood ammonia and endotoxin, between the two groups are significantly different(P<0.05). Conclusion Using Chinese medicine in multi-ways combined with western medicine treated on liver failure is better than western medicine control group. However, considering about the low quality of studies included, we still need a large number of high-quality RCTs to test its efficacy and safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭